
Novel Radioenhancer JNJ-1900 Shows Potential Across Cancers
JNJ-1900 (NBTXR3) shows potential as an innovative approach to enhance local tumor control without escalating systemic toxicity across solid tumors, including lung cancer, according to preliminary findings from an ongoing phase 1 study (NCT03589339) …